LIGAND PHARMACEUTICALS INC Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,706 | 37,396 | 66,625 | |
| Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 7,225 | 104,546 | 7,225 | |
| Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,706 | 37,396 | 155,449 | 153.7 K to 155.4 K (+1.11 %) |
| Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 110.00 | 7,225 | 794,750 | 153,743 | 161 K to 153.7 K (-4.49 %) |
| Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 7,225 | 104,546 | 160,968 | 153.7 K to 161 K (+4.70 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 9.96 | 48,125 | 479,325 | 0 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | A | 95.68 | 60,886 | 5,825,572 | 60,886 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 97.23 | 2,117 | 205,836 | 205,173 | 207.3 K to 205.2 K (-1.02 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 97.23 | 1,310 | 127,371 | 207,290 | 208.6 K to 207.3 K (-0.63 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 97.23 | 1,689 | 164,221 | 208,600 | 210.3 K to 208.6 K (-0.80 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 13,559 | 0 | 210,289 | 196.7 K to 210.3 K (+6.89 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 95.68 | 5,009 | 479,261 | 196,730 | 201.7 K to 196.7 K (-2.48 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 9.96 | 48,125 | 479,325 | 201,739 | 153.6 K to 201.7 K (+31.33 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 95.68 | 33,210 | 3,177,533 | 33,210 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 496 | 10,872 | 68,331 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 7,225 | 104,546 | 14,450 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 1,170 | 113,759 | 153,743 | 154.9 K to 153.7 K (-0.76 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 447 | 43,462 | 154,913 | 155.4 K to 154.9 K (-0.29 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 869 | 84,493 | 155,360 | 156.2 K to 155.4 K (-0.56 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 95.84 | 7,225 | 692,467 | 156,229 | 163.5 K to 156.2 K (-4.42 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 7,225 | 104,546 | 163,454 | 156.2 K to 163.5 K (+4.62 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 7,396 | 0 | 156,229 | 148.8 K to 156.2 K (+4.97 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 496 | 10,872 | 148,833 | 148.3 K to 148.8 K (+0.33 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | A | 95.68 | 17,220 | 1,647,610 | 17,220 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 97.23 | 367 | 35,683 | 52,023 | 52.4 K to 52 K (-0.70 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 97.23 | 207 | 20,127 | 52,390 | 52.6 K to 52.4 K (-0.39 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 97.23 | 307 | 29,850 | 52,597 | 52.9 K to 52.6 K (-0.58 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,835 | 0 | 52,904 | 49.1 K to 52.9 K (+7.82 %) |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Option Exercise | A | 95.68 | 30,750 | 2,942,160 | 30,750 | |
| Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 6,848 | 0 | 26,864 | 20 K to 26.9 K (+34.21 %) |